Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TACLONEX Topical Suspension safely and effectively. See full prescribing information for TACLONEX Topical Suspension. TACLONEX® (calcipotriene and betamethasone dipropionate) topical suspension Initial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
Taclonex® Topical Suspension is indicated for the topical treatment of plaque psoriasis of the scalp and body in patients 12 years and older.
- generic_name
- calcipotriene and betamethasone dipropionate
- product_names
- calcipotriene and betamethasone dipropionate
- ndc
- 50222-501, 50222-501-51, 50222-501-06, 50222-501-66
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en